Clinivantage will have 100 million users across 25 countries by end of 2019: Nilesh Jain, Clinivantage

Clini Vantage


India is presently in a state of transition — economically, demographically and epidemiologically — in terms of health. The country, at present, suffers from the triple burden of disease, the unfinished agenda of infectious diseases, the challenge of non-communicable diseases (NCDs) linked with lifestyle changes and the emergence of new pathogens causing epidemics and pandemics. Non-communicable diseases (NCD) are now the leading cause of death in the country contributing to 60% of deaths. In addition, the health infrastructure is already over-stretched and needs to be strengthened to enable it to confront these challenges in the twenty-first century.

Given the centrality of health in economic development, a paradigm shift in our approach is needed. The health system needs to be strengthened to improve the PROCESS of service delivery like leveraging technology for telemedicine, patient records and documented systems for managing the overall health of the patient. In order to make the health services responsive to the need of the community, it is necessary to improve the functioning of the existing government health infrastructure, leverage PPP and technology to deliver care to the last mile, in rural and urban areas. And last but not least, build skill of the existing staff through latest technology to create a learning environment to enhance skill training activities.

Manish Joshi of NewsBarons provides excerpts of an interaction with Nilesh Jain, Co-founder and Managing Director of Clinivantage who informed ‘Clinivantage is poised to be the game changer in Global healthcare landscape’.

NB: How big is the healthcare segment in India for your services?

Nilesh: To give a sense of the size of global markets, in the USA alone top 10 companies do 8.9 Billion USD in software sales alone and devices; connected devices is around $ 250 Billion. In India, there is only one doctor per 1,700 citizens in India, apart from their unwillingness to work in the rural hinterland of our country. Rural healthcare facilities have poor infrastructure, non-availability of basic requirements. Medical devices industry is still at a nascent stage of development. From 2000-12 pharma industry received 10 billion dollars of FDI, whereas, this industry didn’t even receive 2 % of it. The situation is problematic.
The total industry size is expected to touch USD 280 billion by 2020. The healthcare industry is getting patient-centric, India’s software HCIT is expected to be at $1.45 billion in 2018 with CAGR of 30% y-o-y. Also, with the government emphasizing on the eHealth initiatives such as Mother & Child Tracking System (MCTS) & Facilitation Centre (MCTFC), telemedicine, last mile care amongst other initiatives, the Indian healthcare market is at the onset of a tipping point.

Nilesh Jain
Nilesh Jain

NB: Tell us about Clinivantage and how do you differentiate your service from other similar service platforms

Nilesh: The current care system relies on paper-records, which leads to inefficiencies and impacting the quality of treatment. Technologies like mobility, digitization, cloud storage, big data and AI are changing the way care can be delivered and this is where Clinivantage makes a difference.

Clinivantage Technology is used to streamline processes and address the traditional challenges. Some of the technologies that would shape the future of healthcare industry in India may be PaaS [Platform as a service], IoA [Internet of applications], instant device DoT© (Doctor of Things), IoT integration, AI, ML and telemedicine.

Clinivantage puts patients in greater control of their health. It is an integrated digital platform that connects doctors, hospitals, caregivers and service providers with the patient in real time. By placing the patient at the focal point in the healthcare loop, Clinivantage brings more momentum to the entire healthcare ecosystem, making it work in tandem to provide better outcomes for patients and improved productivity resulting in profitable care for providers.
By digitally empowering healthcare consumers with the inclusion of DoT and AI in its IoA platform, Clinivantage provides a predictive tool to manage health, foster preventive measures and enable chronic disease management.

Clinivantage also provides better monetization opportunities for care providers through the Health Huddle platform, enabling commercialization through telemedicine and communication platforms like What’s App on a much more secured Clinivantage PaaS

Standing at the crossroads of multiple technologies i.e. cloud, mobile, medical and social, Clinivantage spearheads and transforms the practice of digital medicine.

NB: How is technology enhancing healthcare services in India?

Nilesh: Technology has great potential in bringing efficiency in service delivery and enhancing the reach of the health services. Clinivantage completed a PoC in rural Maharashtra where it can, connect remote areas with national centers of excellence and patients in villages; with doctors in hospitals in urban areas through audio or video conferencing, known as “telemedicine”. Clinivantage can be establishing a network of telemedicine services, mother and child tracking system in real time, weekly voice/text messages to pregnant women and new mothers, PaaS based TB management programs, chronic disease management and mobile app for the training of Accredited Social Health Activist (ASHA) workers, upskilling for first level medical connection between rural population and urban district doctors. This is huge!!, technology can enable trained and skilled personnel to deploy and transform last mile care, using existing infrastructure and doctor network.

NB: What is the present geographical reach and association with Doctors/Healthcare providers?

Nilesh: At present, Clinivantage is operational in 7 countries like UK, India, Malaysia, Indonesia, UAE, South Africa and Kenya. We have strong plans to foray into 25 countries including Canada, USA, Australia, New Zealand, Sri Lanka and Norway amongst other by end of 2019.
We have closed deals with 35 hospitals/primary care centers, 105 Clinics, 500+ doctors across 20 super specialties. The focus in to expand to 100M consumers by 2019, we are currently at 10M records in 3 months of deployment.

NB: You have recently announced an association with SAH, Bahrain. Are you looking at more such associations and tell us the advantage of such tie-ups.

Nilesh: At Clinivantage we believe in a strong partnership operational model. We are in 7 countries in such a short time through a strong partner network. Our growth strategy is via building a strong partner network across the geographies we want to scale into. We offer our partners significant benefits, including sharing experience, skills, people, equipment’s and customer bases. Through a partnership arrangement with complementary skills, we can open new markets or improve offerings to existing ones. We are very aggressive in our partner model and believe in an inclusive growth.

NB: You are looking at raising funds? Can you specify the amount and the area of usage?

Nilesh: We have very aggressive goals of expansion and are currently in the process of raising a seed round of investment. The funds will be 40% utilized for scale and expansion across the globe, 30% for product development, 20% for deployment of resources for implementation, 10% for travel and administration.
An unrelenting focus on the customer, we put the customer first in an authentic way. We trusted that building things of value (product) and providing exceptional support (service) for economically viable (money) products would ultimately lead to a good, no, great business as well!

[Nilesh Jain is a serial entrepreneur, with the primary focus on healthcare & technology; an investor and an advisor with passion towards mentoring and consulting start-ups to grow exponentially on a global scale. He has served as a CEO and Co-Founder of more than 5 companies and has a proven track record of building and managing companies. His diverse experience across US and India and in guiding healthcare units in technology & manufacturing apart from others.]